Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Cossart (2004)
Human Parvovirus B19American Journal of Transplantation, 4
H. Zaaijer, M. Koppelman, C. Farrington (2004)
Parvovirus B19 viraemia in Dutch blood donorsEpidemiology and Infection, 132
M. Yu, H. Alter, Maria Virata‐Theimer, Y. Geng, Li Ma, Cathy Schechterly, C. Colvin, N. Luban (2010)
Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samplesTransfusion, 50
Young (2004)
Parvovirus B19N Engl J Med, 350
A. Plentz, J. Hahn, A. Knöll, E. Holler, W. Jilg, S. Modrow (2005)
Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood productsTransfusion, 45
(2000)
Phase IV study of Plas+®SD: hepatitis A (HAV) and parvovirus B19 (B19) safety results
A. Servant, S. Laperche, F. Lallemand, V. Marinho, G. Maur, J. Meritet, A. Garbarg‐Chenon (2002)
Genetic Diversity within Human Erythroviruses: Identification of Three GenotypesJournal of Virology, 76
A. Vyse, N. Andrews, L. Hesketh, R. Pebody (2007)
The burden of parvovirus B19 infection in women of childbearing age in England and WalesEpidemiology and Infection, 135
Hiroyuki Sato, F. Takakura, E. Kojima, K. Fukada, K. Okochi, Y. Maeda (1995)
Screening of blood donors for human parvovirus B19The Lancet, 346
A. Zanella, F. Rossi, C. Cesana, A. Foresti, F. Nador, A. Binda, G. Lunghi, M. Cappellini, M. Furione, G. Sirchia (1995)
Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 35
H. Alter (2008)
Pathogen Reduction: A Precautionary Principle ParadigmTransfusion Medicine Reviews, 22
J. Blümel, I. Schmidt, W. Effenberger, H. Seitz, H. Willkommen, H. Brackmann, J. Löwer, A. Eis-Hübinger (2002)
Parvovirus B19 transmission by heat‐treated clotting factor concentratesTransfusion, 42
M. Kawamura, M. Sawafuji, Masazumi Watanabe, H. Horinouchi, Koichi Kobayashi (2002)
Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery.The Annals of thoracic surgery, 73 4
R. Abe, T. Shichishima, K. Ogawa, Y. Saitoh, Y. Maruyama (2006)
Neutropenia due to Parvovirus B19 Infections in Patients with Paroxysmal Nocturnal HemoglobinuriaActa Haematologica, 116
K. Brown, P. Simmonds (2007)
Parvoviruses and blood transfusionTransfusion, 47
(2009)
Infectivity of B19 positive blood products
(2007)
Netherlands: Transfusion Reactions In Patients Foundation for Hemovigilance
Michael Schmidt, A. Themann, C. Drexler, M. Bayer, G. Lanzer, Eva Menichetti, Sigrid Lechner, Dietmar Wessin, Barbara Prokoph, J. Allain, E. Seifried, Michael Hourfar (2007)
Blood donor screening for parvovirus B19 in Germany and AustriaTransfusion, 47
M. Osaki, K. Matsubara, T. Iwasaki, T. Kurata, H. Nigami, H. Harigaya, K. Baba (1999)
Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying diseaseAnnals of Hematology, 78
S. Kleinman, S. Glynn, Tzong-Hae Lee, L. Tobler, Leilani Montalvo, D. Todd, J. Kiss, V. Shyamala, M. Busch (2007)
Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assayTransfusion, 47
Wakamatsu (1999)
Screening of blood donors for human parvovirus B19 and characterization of the resultsVox Sang, 76
T. Pumarola (1995)
[Parvovirus B19].Medicina clinica, 104 1
Y. Yoto, T. Kudoh, K. Haseyama, N. Suzuki, Takanori Oda, T. Katoh, Tsuneo Takahashi, Sadami Sekiguchi, Shunzo Chiba (1995)
Incidence of human parvovirus B19 DNA detection in blood donorsBritish Journal of Haematology, 91
K. Brown, S. Anderson, N. Young (1993)
Erythrocyte P antigen: cellular receptor for B19 parvovirus.Science, 262 5130
(2011)
National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II). Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive
Y. Takeda, Akemi Wakisaka, K. Noguchi, T. Murozuka, Y. Katsubayashi, Shuzo Matsumoto, Tsugikazu Tomono, Kusuya Nishioka (2001)
Receptor‐mediated haemagglutination screening and reduction in the viral load of parvovirus B19 DNA in immunopurified Factor VIII concentrate (Cross Eight M®)Vox Sanguinis, 81
Jordan (1998)
Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipientsVox Sang, 75
G. Kurtzman, N. Frickhofen, J. Kimball, D. Jenkins, A. Nienhuis, N. Young (1989)
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.The New England journal of medicine, 321 8
K. Groeneveld, J. Noordaa (2003)
Blood products and parvovirus B19.The Netherlands journal of medicine, 61 5
Armen Parsyan, D. Candotti (2007)
Human erythrovirus B19 and blood transfusion – an updateTransfusion Medicine, 17
A. Borne, M. Bos, N. Joustra-Maas, J. Tromp, R. Bois, P. Tetteroo (1986)
A murine monoclonal IgM antibody specific for blood group P antigen (globoside)British Journal of Haematology, 63
(2008)
Tokyo: Japanese Ministry of Health, Labour and Welfare publication
J. Jordan, B. Tiangco, J. Kiss, W. Koch (1998)
Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 75
D. Erdman, B. Anderson, T. Török, T. Finkel, L. Anderson (1997)
Possible transmission of parvovirus B19 from intravenous immune globulinJournal of Medical Virology, 53
Heegaard (2002)
Human parvovirus B19Clin Microbiol Rev, 15
BJ Cohen, S. Beard, WA Knowles, J. Ellis, D. Joske, J. Goldman, P. Hewitt, K. Ward (1997)
Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusionTransfusion, 37
C. Wakamatsu, F. Takakura, E. Kojima, Y. Kiriyama, N. Goto, K. Matsumoto, M. Oyama, Hiroyuki Sato, Kazuo Okochi, Yoshiaki Maeda (1999)
Screening of Blood Donors for Human Parvovirus B19 and Characterization of the ResultsVox Sanguinis, 76
S. Kleinman, S. Glynn, Tzong-Hae Lee, L. Tobler, K. Schlumpf, D. Todd, Hannah Qiao, M. Yu, M. Busch (2009)
A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.Blood, 114 17
BACKGROUND: Although a risk of transfusion‐transmitted human parvovirus B19V (TT‐B19V) infection has been a concern, there have been very few reports of clinically relevant TT‐B19V caused by the transfusion of a B19V‐containing blood component. It has therefore been a matter of debate whether a universal B19V screening with an appropriate sensitivity is required. STUDY DESIGN AND METHODS: Through the Japanese Red Cross hemovigilance system, clinical reports on possible TT‐B19V were collected from 1999 to 2008, during which B19V donor screening (sensitivity, 1010 IU/mL) was conducted and repository blood samples from donors were available. RESULTS: Eight patients with TT‐B19V caused by component transfusion have been identified. Four patients developed sustained anemia and pure red blood cell (RBC) aplasia and one patient developed pancytopenia. The underlying diseases in these five patients were either hematologic malignancy or hemolytic diseases. The viral loads of the responsible components for these cases ranged from 103 to 108 IU/mL. Two patients who underwent surgical treatment without any hematologic disorder exhibited only moderate symptoms. The B19V DNA sequence identity between a patient and the linked blood donor was confirmed in five of the eight patients. All of the components responsible for the eight cases were positive for anti‐B19V immunoglobulin (Ig)M. CONCLUSION: Vulnerability to serious B19V‐related hematologic disorders depended on the patient's underlying disease state of an enhanced erythropoiesis, not on the viral load of the component transfused. To prevent clinically relevant TT‐B19V, a strategy is suggested in which patients at risk of acquiring RBC aplasia or pancytopenia are targeted.
Transfusion – Wiley
Published: Sep 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.